Treatment modalities have seen remarkable progress with the introduction of minimally invasive surgeries for congenital defects, reducing the recovery time and risk of complications. The use of stem cell therapy has shown promise in treating disorders like spina bifida and hypoxic-ischemic encephalopathy. Moreover, advancements in pharmacotherapy have led to the development of targeted drugs that address specific neonatal conditions effectively.
